Literature DB >> 4723256

Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.

G H Evans, D G Shand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4723256     DOI: 10.1002/cpt1973144part1494

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  33 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  The distribution of propranolol between blood and plasma in hypertensive patients.

Authors:  R J Sawchuk; J Robayo; K W Miller
Journal:  Br J Clin Pharmacol       Date:  1974-10       Impact factor: 4.335

3.  The distribution of quinidine in human blood.

Authors:  I E Hughes; K F Ilett; L B Jellett
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

4.  Pharmacokinetics of propranolol in normal healthy volunteers.

Authors:  R Gomeni; G Bianchetti; R Sega; P L Morselli
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

Review 5.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

6.  Influence of physical exercise on the pharmacokinetics of propranolol.

Authors:  B G Arends; R O Böhm; J E van Kemenade; K H Rahn; M A van Baak
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists.

Authors:  E A Taylor; D Jefferson; J D Carroll; P Turner
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

8.  A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.

Authors:  R A Branch; J James; A E Read
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

Review 9.  Clinical pharmacokinetics of pethidine.

Authors:  L E Mather; P J Meffin
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

Review 10.  Propranolol disposition in chronic liver disease: a physiological approach.

Authors:  R A Branch; D G Shand
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.